期刊文献+

高效液相色谱手性固定相的最新研究进展 被引量:2

The Latest Development of Research of the Chiral Stationary Phase in HPLC
下载PDF
导出
摘要 综述高效液相色谱手性固定相的发展过程,介绍手性冠醚类、Pirkle型、配体交换型、大环抗生素、多糖类、环糊精类、分子印迹类、蛋白质类、手性聚合物类手性固定相在2006-2007年的发展过程,展望高效液相色谱手性固定相的发展前景。 This article is intended to foresee the outlook for the development of the chiral stationary phase in HPLC by reviewing the history of the chiral stationary phase in HPLC and introducing the development of such chiral stationary phases as chloroform, Pirkle-type, Ligand Exchange, Macrocyclic Antibiotics, Polysaccharide, Cyclodextrin, Molecularly Imprinted Polymer, protein and chiral polymers in 2006-2007.
作者 赵峰
出处 《昭通师范高等专科学校学报》 2008年第5期10-18,共9页 Journal of Zhaotong Teacher's College
关键词 高效液相色谱 手性固定相 手性拆分 HPLC the chiral stationary phase the chiral seperation
  • 相关文献

参考文献1

二级参考文献6

  • 1G.Subramanian.A Practical Approach to Chiral Separations by Liquid Chromatography[]..1994
  • 2W.H.Pirkle,,T.C.Pochapsky. Chemical Reviews . 1989
  • 3O.R.Malyshev,,M.G.Vinogradov. Journal of Chromatography A . 1999
  • 4A.Ranogajec,,D.Kontrec,,V.Vinkovic,,V.Sunjic. J.Liq.Chromatogr.Rel.Technol . 2003
  • 5P.Murer,,K.Lewandowski,,F.Svec,,J.M.J.Frechet. Analytical Chemistry . 1999
  • 6A.Satinder.Chiral Separation—Applications and Technology[]..1997

共引文献2

同被引文献22

  • 1张春艳,袁牧,黄碧云,季红,朱柳.柱前衍生化RP-HPLC分离巴氯芬的对映异构体[J].华西药学杂志,2008,23(3):342-343. 被引量:5
  • 2易大为,王璐,杨荣珍,于天凤.手性流动相测定盐酸左氧氟沙星的含量[J].中国药品标准,2006,7(3):29-31. 被引量:5
  • 3薛娜,牛长群.苯磺酸左旋氨氯地平的毛细管电泳手性分离与纯度检查[J].中国医院药学杂志,2007,27(1):51-53. 被引量:7
  • 4[1]INDU B,RAJINDER P,GULAM NQ,et al.Lipase enzyme immobilization on synthetic beaded macroporous copolymers for kinetic resolution of chiral drugs intermediates[J].Process Biochemistry,2008,43(4):321-330.
  • 5[2]KIDWELL GA,LIMA JJ,SCHAAL SF,et al.Hemodynamic and electrophysiologic effects of the enantiomers of disopyramide in a canine blood superfusion model[J].J Cardiovasc Pharmacol,1989,13(4):644-655.
  • 6[3]GOODWIN SD,GALLIS HA,CHOW AT,et al.Pharmacology and safety of levofloxacin in patients with human immunodeficiency virus infection[J].Antimicrob Agents Chemother,1994,38(4):799-804.
  • 7[4]DRAYER DE.Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans:an overview[J].Clin Pharmacol Ther,1986,40(2):125-133.
  • 8[5]ERIKSSON T,BJORKMAN S,ROTH B,et al.Enantiomers of thalidomide:blood distribution and the influence of serum albumin on chiral inversion and hydrolysis[J].Chiralty,1998,10(3):223.
  • 9[6]KROEMER HK,FROMM MF,BUHL K,et al.An enantiomer-enantiomer interaction of (s)-and (r)-propafenone modifies the effect of racemic drug therapy[J].Circulation,1994,89(2):2396-2400.
  • 10[7]NERUKAR SG,DIGHE SV,WILLIAMS R,et al.Bioequivalence of racemic drugs[J].J Clin Pharmacol,1992,32(10):935-943.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部